2008-2013 Biochemist, University of Buenos Aires School of Pharmacy and Biochemistry, Argentina.
2013-2022 Pharmacist, University of Buenos Aires School of Pharmacy and Biochemistry, Argentina.
2014-2017 Residency. Biochemistry-Clinical Immunology. “Pedro de Elizalde” General Children´s Hospital (Hospital General de Niños “Pedro de Elizalde”), Buenos Aires, Argentina.
2017-2018 Chief of Residents. Biochemistry-Clinical Immunology. “Pedro de Elizalde” General Children´s Hospital (Hospital General de Niños “Pedro de Elizalde”), Buenos Aires, Argentina.
2018-2022 Ph.D., Pharmacy and Biochemistry, University of Buenos Aires, Argentina.

I worked as a teaching assistant in Immunology at the University of Buenos Aires, School of Pharmacy and Biochemistry, School of Medicine, and at “José de San Martin” University Hospital, Buenos Aires, Argentina. Throughout my four-year residency, I worked actively in the fields of HIV/AIDS, inborn errors of immunity, autoimmune diseases,  hematological malignancies and transplantation. I obtained the Clinical Immunology Board Certification from the Buenos Aires Official College of Pharmacy and Biochemistry (2019). In 2018, I obtained a doctoral scholarship from the Argentinian National Council for Scientific and Technical Research (CONICET). I began working at the Institute for Biomedical Research on Retroviruses and AIDS (INBIRS) at the University of Buenos Aires as a PhD Student. My project was focused on the HIV viral reservoir dynamics and immune response in people living with HIV and HCV. I currently work in the Transplantation Immunology field at the University of Maryland, School of Medicine, Surgery Department.

Transplantation, Immunology, Genomics.

1. Urioste A, Capecce E, Holoveski L, Cantisano C, Balbaryski J, Gaddi E. “Prevalence and characteristics of hypergammaglobulinemias in a pediatric population”. Revista Pediátrica Elizalde; 7 (1): 17– 21. 2016. (in spanish).
2. Barboni G, Balbaryski J, Urioste A, Candi M, Laucella S, Gaddi E. “Restoration of recent thymic emigrant CD4+ T cells is associated with sustained adherence to antiretroviral treatment in HIV-infected children”. Scand J Immunol.;00:e12838. 2019.
3. Polo ML, Ghiglione Y, Salido J, Urioste A, Poblete G, Sisto A, Martinez A, Rolón MJ, Ojeda D, Cahn P, Turk G, Laufer N. “Liver cirrhosis in HIV/HCV‐coinfected individuals is related to NK cell dysfunction and exhaustion, but not to an impaired NK cell modulation by CD4+ T‐cells”. J Int AIDS Soc.; 22(9): e25375. 2019.
4. Urioste A, Polo ML, Trifone C, Turk G, Laufer N. ”Systemic inflammation and immune dysregulation: role in the pathogenesis of HIV / HCV coinfection”. Actualizaciones en sida e infectología; 28 (102): 30-37. 2020. (in spanish).
5. Ghiglione Y, Polo ML, Urioste A, Rhodes A, Czernikier A, Trifone C, Quiroga MF, Sisto A, Patterson P, Salomón H, Rolón MJ, Bakkour S, Lewin S, Turk G, Laufer N. “Hepatitis C Virus (HCV) Clearance After Treatment With Direct-Acting Antivirals in Human Immunodeficiency Virus (HIV)-HCV Coinfection Modulates Systemic Immune Activation and HIV Transcription on Antiretroviral Therapy”. Open Forum Infect Dis.; 7(5):ofaa115. 2020.
6. Salido J, Czernikier A, Trifone C, Polo ML, Figueroa MI, Urioste A, Cahn P, Sued O, Salomon H, Laufer N, Ghiglione Y, Turk G. “Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After effective cART”. Pathogens and Immunity; 6(2): 60–89. 2021.
7. Urioste A. “Immunological markers in the study of HIV infection: contributions from the clinical laboratory. An update”. Acta Bioquímica Clínica Latinoamericana, 57(2). ISSN: 0325-2957. 2023. (in spanish).
8. Yaffe HC, von Ahrens D, Urioste A, Mas VR, Akalin E. ”Impact of Deceased-donor Acute Kidney Injury on Kidney Transplantation”. Transplantation. doi: 10.1097/TP.0000000000004848. Epub ahead of print. PMID: 37990359. 2023.
9. Osegueda A, Polo ML, Baquero L, Urioste A, Ghiglione Y, Paz S, Poblete G, Gonzalez Polo V, Turk G, Quiroga MF, Laufer N. ”Markers of Natural Killer Cell Exhaustion in HIV/HCV Coinfection and Their Dynamics After HCV Clearance Mediated by Direct-Acting Antivirals”. Open Forum Infect Dis.;10(12):ofad591. 2023.